TrialBioMed research international2015

The Diagnostic Ability of Follow-Up Imaging Biomarkers after Treatment of Glioblastoma in the Temozolomide Era: Implications from Proton MR Spectroscopy and Apparent Diffusion Coefficient Mapping.

Martin Bulik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.